陈虹, 汤文娟
Abstract
目的:评价AFP、CEA、CA125在卵巢癌诊断和监测中的应用价值.方法:应用化学发光免疫方法检测47例正常妇女,62例卵巢良性肿瘤,12例卵巢巧克力囊肿,41例卵巢恶性肿瘤患者血清AFP、CEA、CA125值并进行比较分析.结果:卵巢恶性肿瘤患者AFP、CEA、CA125阳性率分别为9.7%、26.8%和82.9%,显著高于卵巢良性肿瘤和正常妇女.在绝大多数正常妇女和卵巢良性肿瘤中,AFP、CEA、CA125在参考值范围内,卵巢巧克力囊肿CA125有一定程度升高.在卵巢恶性肿瘤中,晚期患者血清CA125浓度和阳性率都显著高于早期患者.结论:AFP、CEA、CA125联合应用对于卵巢癌的诊断和监别诊断及提高总的异常检出率具有价值.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
目的:评价AFP、CEA、CA125在卵巢癌诊断和监测中的应用价值.方法:应用化学发光免疫方法检测47例正常妇女,62例卵巢良性肿瘤,12例卵巢巧克力囊肿,41例卵巢恶性肿瘤患者血清AFP、CEA、CA125值并进行比较分析.结果:卵巢恶性肿瘤患者AFP、CEA、CA125阳性率分别为9.7%、26.8%和82.9%,显著高于卵巢良性肿瘤和正常妇女.在绝大多数正常妇女和卵巢良性肿瘤中,AFP、CEA、CA125在参考值范围内,卵巢巧克力囊肿CA125有一定程度升高.在卵巢恶性肿瘤中,晚期患者血清CA125浓度和阳性率都显著高于早期患者.结论:AFP、CEA、CA125联合应用对于卵巢癌的诊断和监别诊断及提高总的异常检出率具有价值.
Key concepts: Medicine, Ovarian cancer, Internal medicine, Oncology, Cancer